Return to search

Biopharma company Poxel closes private placement

Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement.

Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement. The investors included Bpifrance Participations.

Source: Press Release